Cesca Therapeutics Inc. , an autologous cell-based regenerative medicine company, today reported financial results for the second quarter of fiscal 2015 and provided an update on the progress of its clinical programs. "We made good progress in advancing our cell therapy programs during the second quarter of fiscal 2015," said Robin C. Stracey, Chief Executive Officer of Cesca Therapeutics.
http://ift.tt/1KTxpB1
http://ift.tt/1KTxpB1
No comments:
Post a Comment